Andelyn Biosciences: Valuation, Funding & Investors
Andelyn Biosciences is a contract development and manufacturing organization (CDMO) that provides process development, analytical services, and cGMP manufacturing for biologics and cell & gene therapy products. The company supports viral vectors, plasmids, and other complex biologics across preclinical through commercial phases, and offers quality, regulatory, and supply chain capabilities to biopharmaceutical partners.
Leadership & Board
- Current Number of Employees
- 278
- Current LinkedIn Followers
- 12,092
Latest Estimated Valuation
- Total Amount Raised
- $5M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $5M
- Latest Funding Round
- Investment
Company Momentum
PositiveAndelyn Biosciences LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Andelyn Biosciences had 278 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Andelyn Biosciences had 12,092 followers as of November 16, 2026. The number of followers increased by 19 (0.16%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Mar 08, 2022 | Investment | $5.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| JobsOhio | Investment |
Similar Companies
A snapshot of private companies similar to Andelyn Biosciences, helping you discover and navigate related company profiles.
Related News and Analysis








